60 – Development and validation of a GMP production protocol for a cord blood-derived dendritic cell-based vaccine to prevent relapses after hematopoietic cell transplantation in children with AML
2017
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI